{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:40:42Z","timestamp":1760128842948,"version":"build-2065373602"},"reference-count":22,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pfizer"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: The increased focus on quality indicators (QIs) and the use of clinical registries in real-world cancer studies have increased compliance with therapeutic standards and patient survival. The European Society of Breast Cancer Specialists (EUSOMA) established QIs to assess compliance with current standards in breast cancer care. Methods: This retrospective study is part of H360 Health Analysis and aims to describe compliance with EUSOMA QIs in breast cancer management in different hospital settings (public vs. private; general hospitals vs. oncology centers). A set of key performance indicators (KPIs) was selected based on EUSOMA and previously identified QIs. Secondary data were retrieved from patients\u2019 clinical records. Compliance with target KPIs in different disease stages was compared with minimum and target EUSOMA standards. Results: A total of 259 patient records were assessed. In stages I, II, and III, 18 KPIs met target EUSOMA standards, 5 met minimum standards, and 8 failed to meet minimum standards. Compliance with KPIs varied according to the type of hospital (particularly regarding diagnosis) and disease stage. Although small differences were found in KPI compliance among institutions, several statistical differences were found among treatment KPIs according to disease stage, particularly in stage III. Conclusions: This study represents the first assessment of the quality of breast cancer care in different hospital settings in Portugal and shows that, although most QIs meet EUSOMA standards, there is room for improvement. Differences have been found across institutions, particularly between oncology centers and general hospitals, in diagnosis and compliance with KPIs among disease stages. Stage III showed the greatest variability in compliance with treatment KPIs, probably related to the lower specificity of the guidelines in this disease stage.<\/jats:p>","DOI":"10.3390\/curroncol30070451","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T05:39:13Z","timestamp":1687757953000},"page":"6041-6065","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["360 Health Analysis (H360)\u2014A Comparison of Key Performance Indicators in Breast Cancer Management across Health Institution Settings in Portugal"],"prefix":"10.3390","volume":"30","author":[{"given":"In\u00eas Brand\u00e3o","family":"Rego","sequence":"first","affiliation":[{"name":"Institute of Health Sciences, Universidade Cat\u00f3lica Portuguesa, Palma de Cima, 1649-023 Lisboa, Portugal"},{"name":"Hospital de S\u00e3o Jo\u00e3o, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, 4200-319 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5111-5543","authenticated-orcid":false,"given":"Sara","family":"Coelho","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Universidade Cat\u00f3lica Portuguesa, Palma de Cima, 1649-023 Lisboa, Portugal"},{"name":"Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil EPE, 4200-072 Porto, Portugal"}]},{"given":"Patr\u00edcia Miguel","family":"Semedo","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Universidade Cat\u00f3lica Portuguesa, Palma de Cima, 1649-023 Lisboa, Portugal"},{"name":"Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, 1649-028 Lisboa, Portugal"},{"name":"Instituto de Medicina Molecular-Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8737-0439","authenticated-orcid":false,"given":"Joana","family":"Cavaco-Silva","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Universidade Cat\u00f3lica Portuguesa, Palma de Cima, 1649-023 Lisboa, Portugal"},{"name":"ScienceCircle-Scientific and Biomedical Consulting, 1600-369 Lisboa, Portugal"}]},{"given":"Laetitia","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Universidade Cat\u00f3lica Portuguesa, Palma de Cima, 1649-023 Lisboa, Portugal"},{"name":"Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0680-474X","authenticated-orcid":false,"given":"Susana","family":"Sousa","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Universidade Cat\u00f3lica Portuguesa, Palma de Cima, 1649-023 Lisboa, Portugal"},{"name":"Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal"}]},{"given":"Joana","family":"Reis","sequence":"additional","affiliation":[{"name":"Hospital de S\u00e3o Jo\u00e3o, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, 4200-319 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2101-0027","authenticated-orcid":false,"given":"Rui","family":"Dinis","sequence":"additional","affiliation":[{"name":"Hospital do Esp\u00edrito Santo de \u00c9vora, 7000-811 \u00c9vora, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1006-6946","authenticated-orcid":false,"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina da Universidade do Porto, 4200-319 Porto, Portugal"}]},{"given":"No\u00e9mia","family":"Afonso","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Vila Nova de Gaia e Espinho, 4400-129 Vila Nova de Gaia, Portugal"}]},{"given":"Jos\u00e9 Lu\u00eds","family":"Fougo","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina da Universidade do Porto, 4200-319 Porto, Portugal"},{"name":"Centro de Mama, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, 4200-319 Porto, Portugal"}]},{"given":"Francisco","family":"Pav\u00e3o","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Universidade Cat\u00f3lica Portuguesa, Palma de Cima, 1649-023 Lisboa, Portugal"}]},{"given":"Ricardo","family":"Baptista Leite","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Universidade Cat\u00f3lica Portuguesa, Palma de Cima, 1649-023 Lisboa, Portugal"},{"name":"Faculty of Health, Medicine and Life Sciences, Maastricht University, 6211 LK Maastricht, The Netherlands"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-7318","authenticated-orcid":false,"given":"Lu\u00eds","family":"Costa","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Universidade Cat\u00f3lica Portuguesa, Palma de Cima, 1649-023 Lisboa, Portugal"},{"name":"Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, 1649-028 Lisboa, Portugal"},{"name":"Instituto de Medicina Molecular-Jo\u00e3o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3747\/co.23.2789","article-title":"Identification of performance indicators across a network of clinical cancer programs","volume":"23","author":"Khare","year":"2016","journal-title":"Curr. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejca.2017.08.017","article-title":"Quality indicators in breast cancer care: An update from the EUSOMA working group","volume":"86","author":"Biganzoli","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.breast.2020.02.003","article-title":"The requirements of a specialist breast centre","volume":"51","author":"Biganzoli","year":"2020","journal-title":"Breast"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Cowppli-Bony, A., Tretarre, B., Marrer, E., Defossez, G., Daubisse-Marliac, L., Coureau, G., Minicozzi, P., Woronoff, A.S., Delafosse, P., and Molinie, F. (2019). Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224275"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5152\/ejbh.2020.5144","article-title":"360 Health Analysis (H360)\u2014A Proposal for an Integrated Vision of Breast Cancer in Portugal","volume":"16","author":"Coelho","year":"2020","journal-title":"Eur. J. Breast Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/intqhc\/mzs020","article-title":"Feasibility of evaluating quality cancer care using registry data and electronic health records: A population-based study","volume":"24","author":"Caldarella","year":"2012","journal-title":"Int. J. Qual. Health Care"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Sacerdote, C., Bordon, R., Pitarella, S., Mano, M.P., Baldi, I., Casella, D., Di Cuonzo, D., Frigerio, A., Milanesio, L., and Merletti, F. (2013). Compliance with clinical practice guidelines for breast cancer treatment: A population-based study of quality-of-care indicators in Italy. BMC Health Serv. Res., 13.","DOI":"10.1186\/1472-6963-13-28"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.breast.2011.10.003","article-title":"Developing and measuring a set of process and outcome indicators for breast cancer","volume":"21","author":"Stordeur","year":"2012","journal-title":"Breast"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/jep.12436","article-title":"Indicators based on registers and administrative data for breast cancer: Routine evaluation of oncologic care pathway can be implemented","volume":"22","author":"Andreano","year":"2016","journal-title":"J. Eval. Clin. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10549-019-05186-z","article-title":"Explaining variation in quality of breast cancer care and its impact: A nationwide population-based study from Slovenia","volume":"175","author":"Plavc","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijmedinf.2019.03.004","article-title":"Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry","volume":"125","author":"Schlichting","year":"2019","journal-title":"Int. J. Med. Inform."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.ejca.2010.06.119","article-title":"Quality indicators in breast cancer care","volume":"46","author":"Ponti","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1245\/s10434-015-4759-x","article-title":"Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference","volume":"22","author":"Landercasper","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.ejca.2015.03.013","article-title":"Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: A European Society of Breast Cancer Specialists database analysis","volume":"51","author":"Kiderlen","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/jamasurg.2014.926","article-title":"Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: A report from the National Cancer Data Base, 2004\u20132010","volume":"149","author":"Wilke","year":"2014","journal-title":"JAMA Surg."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Fisher, S., Gao, H., Yasui, Y., Dabbs, K., and Winget, M. (2015). Treatment variation in patients diagnosed with early stage breast cancer in Alberta from 2002 to 2010: A population-based study. BMC Health Serv. Res., 15.","DOI":"10.1186\/s12913-015-0680-z"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1245\/s10434-012-2693-8","article-title":"Factors Influencing Surgical and Adjuvant Therapy in Stage I Breast Cancer: A SEER 18 Database Analysis","volume":"20","author":"Showalter","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.breast.2014.11.014","article-title":"Quality of care in breast cancer centers: Results of benchmarking by the German Cancer Society and German Society for Breast Diseases","volume":"24","author":"Kowalski","year":"2015","journal-title":"Breast"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bandarra, M.C.F., Escoval, A., Lopes, A., Abreu, C., Sim\u00f5es, J., Brito, M., Dinis, R., Alves, S., P\u00f3voa, S., and Oliveira, S.D. (Poster, 2023). PERSONA study: Optimization of the value-based healthcare as for the follow-up of women with breast cancer\u2014A portrait of breast cancer survivor\u2019s follow-up in Portugal, Poster, in press.","DOI":"10.1016\/S0960-9776(23)00254-0"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/7\/451\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:59:27Z","timestamp":1760126367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/7\/451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["curroncol30070451"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30070451","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2023,6,23]]}}}